Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹542 Cr₹419 Cr₹1,066 Cr₹921 Cr₹1,218 Cr

What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS is ₹542 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹542 Cr
Mar2024₹419 Cr
Mar2023₹1,066 Cr
Mar2022₹921 Cr
Mar2021₹1,218 Cr

How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹542 Cr
29.25
Mar2024 ₹419 Cr
-60.66
Mar2023 ₹1,066 Cr
15.71
Mar2022 ₹921 Cr
-24.36
Mar2021 ₹1,218 Cr -

Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,513.6 Cr -1.7% -8.8% 45.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,513.0 Cr 0.4% -4.6% 6.9% Stock Analytics
DIVIS LABORATORIES ₹176,570.0 Cr 0.7% -1.1% 2.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,670.0 Cr 2.9% -1.2% 42.7% Stock Analytics
CIPLA ₹111,725.0 Cr -1.5% 5.5% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹106,424.0 Cr 0.4% -0.6% 1.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.7%

-8.8%

45.7%

SENSEX

-0.7%

-2.9%

-8.9%


You may also like the below Video Courses